Condition
Neonatal Cholestasis
Total Trials
6
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown4
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06628726Not ApplicableNot Yet RecruitingPrimary
Liver Biopsy in Diagnosis Neonatal Jaundice
NCT06048211UnknownPrimary
Impact of the Stool Color Scale on the Detection of Neonatal Cholestasis
NCT03842150Unknown
Development and Validation of a Screening Score for the Biliary Atresia in Infantile Cholestasis: A Prospective Study
NCT05163145UnknownPrimary
Risk Factor for Cholestasis in Neonates Receiving TPN(Total Parenteral Nutrition)
NCT03898765Not ApplicableUnknown
Dry Blood Spot Screening Test for Biliary Atresia（DBS-SCReBA）
NCT01875510Not ApplicableCompleted
The Influence of Fish-oil Lipid Emulsions on Neonatal Morbidities
Showing all 6 trials